SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19

被引:13
作者
Liang, Hong-Yu [1 ]
Wu, Yuyan [2 ,3 ]
Yau, Vicky [4 ]
Yin, Huan-Xin [1 ]
Lowe, Scott [5 ]
Bentley, Rachel [5 ]
Ahmed, Mubashir Ayaz [6 ]
Zhao, Wenjing [7 ]
Sun, Chenyu [7 ]
机构
[1] Anhui Med Univ, Sch Clin Med 2, Hefei 230032, Peoples R China
[2] First Peoples Hosp Hefei, 390 N Huaihe Rd, Hefei 230061, Peoples R China
[3] Philippine Womens Univ, Sch Nursing, 1743 Taft Ave, Manila 1004, Philippines
[4] Columbia Univ, Div Oral & Maxillofacial Surg, Irving Med Ctr, 622W 168th St, New York, NY 10032 USA
[5] Kansas City Univ, Coll Osteopath Med, 1750 Independence Ave, Kansas City, MO 64106 USA
[6] AMITA Hlth St Joseph Hosp Chicago, 2900 N Lake Shore Dr, Chicago, IL 60657 USA
[7] Yangzhou Univ, Northern Jiangsu Peoples Hosp, Nantong Western Rd 98, Yangzhou 225000, Jiangsu, Peoples R China
关键词
COVID-19; SARS-CoV-2; variants; vaccines; molecular therapeutic target; RECEPTOR-BINDING DOMAIN; DELTA VARIANT; MUTATIONS; ESCAPE; SPIKE; ACE2; NEUTRALIZATION; INFECTION; ANAKINRA; SCOTLAND;
D O I
10.3390/vaccines10091538
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Over the past two years, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused hundreds of millions of infections, resulting in an unprecedented pandemic of coronavirus disease 2019 (COVID-19). As the virus spreads through the population, ongoing mutations and adaptations are being discovered. There is now substantial clinical evidence that demonstrates the SARS-CoV-2 variants have stronger transmissibility and higher virulence compared to the wild-type strain of SARS-CoV-2. Hence, development of vaccines against SARS-CoV-2 variants to boost individual immunity has become essential. However, current treatment options are limited for COVID-19 caused by the SARS-CoV-2 variants. In this review, we describe current distribution, variation, biology, and clinical features of COVID-19 caused by SARS-CoV-2 variants (including Alpha (B.1.1.7 Lineage) variant, Beta (B.1.351 Lineage) variant, Gamma (P.1 Lineage) variant, Delta (B.1.617.2 Lineage) variant, and Omicron (B.1.1.529 Lineage) variant and others. In addition, we review currently employed vaccines in clinical or preclinical phases as well as potential targeted therapies in an attempt to provide better preventive and treatment strategies for COVID-19 caused by different SARS-CoV-2 variants.
引用
收藏
页数:27
相关论文
共 50 条
  • [21] Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
    Fernandes, Queenie
    Inchakalody, Varghese Philipose
    Merhi, Maysaloun
    Mestiri, Sarra
    Taib, Nassiba
    El-Ella, Dina Moustafa Abo
    Bedhiafi, Takwa
    Raza, Afsheen
    Al-Zaidan, Lobna
    Mohsen, Mona O.
    Al-Nesf, Mariam Ali Yousuf
    Hssain, Ali Ait
    Yassine, Hadi Mohamad
    Bachmann, Martin F.
    Uddin, Shahab
    Dermime, Said
    ANNALS OF MEDICINE, 2022, 54 (01) : 524 - 540
  • [22] Neutralization assays for SARS-CoV-2: Implications for assessment of protective efficacy of COVID-19 vaccines
    Mukhopadhyay, Labanya
    Gupta, Nivedita
    Yadav, Pragya D.
    Aggarwal, Neeraj
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2022, 155 (01) : 105 - 122
  • [23] Effectiveness of COVID-19 Vaccines and Antiviral Therapies in the Era of SARS-CoV-2 Variants
    Unuvar, Gamze Kalin
    Rello, Jordi
    Alp, Emine
    ERCIYES MEDICAL JOURNAL, 2023, 45 (01) : 1 - 7
  • [24] Effectiveness of COVID-19 Vaccines and Antiviral Therapies in the Era of SARS-CoV-2 Variants
    Unuvar, Gamze Kalin
    Rello, Jordi
    Alp, Emine
    JOURNAL OF CLINICAL PRACTICE AND RESEARCH, 2023, 45 (01): : 1 - 7
  • [25] COVID-19: Structural Considerations for Virus Pathogenesis, Therapeutic Strategies and Vaccine Design in the Novel SARS-CoV-2 Variants Era
    Volkan, Ender
    MOLECULAR BIOTECHNOLOGY, 2021, 63 (10) : 885 - 897
  • [26] Current Updates on Variants of SARS-CoV-2: Systematic Review
    Erkihun, Mulat
    Ayele, Bayu
    Asmare, Zelalem
    Endalamaw, Kirubel
    HEALTH SCIENCE REPORTS, 2024, 7 (11)
  • [27] Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2
    Bilal, Muhammad
    Iqbal, Hafiz M. N.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (12) : 3034 - 3042
  • [28] Implications of COVID-19 vaccine boosters amid the emergence of novel variants of SARS-CoV-2
    Dhawan, Manish
    Bin Emran, Talha
    Choudhary, Om Prakash
    ANNALS OF MEDICINE AND SURGERY, 2022, 77
  • [29] COVID-19 vaccines and decreased transmission of SARS-CoV-2
    A. Vitiello
    F. Ferrara
    V. Troiano
    R. La Porta
    Inflammopharmacology, 2021, 29 : 1357 - 1360
  • [30] COVID-19: implications of SARS-CoV-2 in Colombia
    Almeida-Espinosa, Alexander
    Sarmiento-Ardila, Jorge A.
    GACETA MEDICA DE MEXICO, 2020, 156 (04): : 334 - 338